Marked pregnancy-induced insulin resistance may require that patient receive high-dose large-volume insulin injections. However, these types of injections may reduce the therapeutic effectiveness of the insulin.
In this episode of the Better Edge podcast, Grazia Aleppo, MD, and Emily D. Szmuilowicz, MD, discuss their recent research published in Postgraduate Medicine. Their research proposes a new treatment regimen for pregnancy-induced insulin resistance that is guided by continuous glucose monitoring (CGM). This aims to give internists and family medicine physicians a simplified and consistent approach to CGM interpretation that can be easily implemented in a brief office visit.
